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Letters to the Editor 
Lui K. J. (2006). Interval estimation of risk difference in simple compliance randomized trials.  Journal of 
Modern Applied Statistical Methods, 5, 395–407. 
 
Ian R. White 
MRC Biostatistics Unit 
 
 
Professor Lui (2006) reports a careful 
comparison of the properties of six possible 
interval estimators for the causal risk difference 
among treatment-compliers1. He recommends 
for general use the confidence interval based on 
a tanh-1 transformation of the causal risk 
difference, on the grounds that it has at least the 
nominal coverage and it has the smallest mean 
length of all the methods. 
However, the second of these criteria is 
not self-evidently the most relevant, and there 
are other possible criteria which would point to a 
different choice of interval estimator. 
 
1. Some interval estimators with large mean 
length are valuable and in common use. An 
example is the number needed to treat, 
defined as the inverse of the risk difference. 
The appropriate confidence interval for the 
number needed to treat includes the inverse 
of all values in the confidence interval for 
the risk difference: in particular, it includes 
infinity if the confidence interval for the risk 
difference includes zero2. This interval in 
fact has infinite mean length, but it remains 
appropriate and widely used, if sometimes 
misunderstood. 
2. More generally, mean confidence interval 
length is a scale-dependent criterion: when 
the parameter is transformed to a different 
scale, confidence intervals retain their 
coverage properties but not their mean 
length. Thus mean length on different scales 
could have been considered. 
3. Rather than require coverage to be at least 
the nominal coverage, one could require 
coverage that is close to the nominal 
coverage. Professor Lui’s recommended 
method has over 98% coverage for nominal 
95% confidence intervals in many of the 
simulation settings. 
 
 
4. A further criterion in the treatment-
compliance setting is that one could require 
confidence intervals to agree with the 
intention-to-treat P-value, by excluding zero 
if and only if the intention-to-treat test is 
significant. This is an appropriate 
requirement because the null hypotheses for 
the intention-to-treat and compliance-
adjusted analyses are the same and there is 
no gain in power from allowing for non-
compliance in this setting3. Confusion in 
interpretation could easily arise if 
adjustment for non-compliance in a 
particular data set appeared to change a non-
significant result into a significant one or 
vice versa.  
 
The Fieller’s theorem confidence interval has 
properties 3 and 4 above4. By its derivation, it 
agrees exactly with the intention-to-treat P-value 
computed from an asymptotic test (use of an 
exact intention-to-treat test would make the 
equivalence only approximate). Its coverage is 
therefore close to the nominal, as shown in 
Professor Lui’s simulation study. I therefore 
believe that the Fieller’s theorem confidence 
interval should also be considered for use in 
practice, especially when testing the null 
hypothesis of no intervention effect is important. 
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